BCM
HUMA icon

Brookstone Capital Management’s Humacyte HUMA Stock Holding History

Brookstone Capital Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3K Buy
13,254
+1,401
+12% +$1.3K ﹤0.01% 1308
2026
Q1 		$7.19K Sell
11,853
-2
-0% -$2 ﹤0.01% 1202
2025
Q4 		$11.4K Buy
11,855
+100
+0.9% +$142 ﹤0.01% 1161
2025
Q3 		$20.5K Hold
11,755
– – ﹤0.01% 1131
2025
Q2 		$24.6K Buy
11,755
+250
+2% +$480 ﹤0.01% 1056
2025
Q1 		$19.6K Buy
11,505
+400
+4% +$1.5K ﹤0.01% 1008
2024
Q4 		$56.1K Buy
+11,105
New +$54.9K ﹤0.01% 978

Other funds holding HUMA

UAS
United Asset Strategies Garden City, New York $1.41B AUM 27.73% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CWA
Clarus Wealth Advisors Peoria, Arizona $260M AUM 27.97% 1-Year Est. Return
VMMC
V.M. Manning & Co Greenville, South Carolina $117M AUM
HLA
Hamilton Lane Advisors Conshohocken, Pennsylvania $149M AUM 14.17% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
TC
Trilogy Capital Irvine, California $2.58B AUM 22.97% 1-Year Est. Return
CIAS
CFS Investment Advisory Services Totowa, New Jersey $1.5B AUM 20.41% 1-Year Est. Return

Brookstone Capital Management's HUMA Position: Q2 2026 in Review

Brookstone Capital Management increased its Humacyte (HUMA) stake by 12% in Q2 2026, buying an estimated $1.3K and bringing the position to 13,254 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1308.

Brookstone Capital Management first reported a position in HUMA in Q4 2024 and has held it in 7 quarters since. The position peaked at $56.1K in Q4 2024. 20 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Brookstone Capital Management held 13,254 shares of Humacyte worth $10.3K as of Q2 2026.
  • Brookstone Capital Management bought 1,401 Humacyte shares in Q2 2026, an estimated $1.3K.
  • Humacyte made up ﹤0.01% of Brookstone Capital Management's portfolio in Q2 2026, its #1308 holding.
  • Brookstone Capital Management first reported a position in Humacyte in Q4 2024 and has held it in 7 quarters since.
  • Brookstone Capital Management's Humacyte position peaked at $56.1K in Q4 2024.
  • 20 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.